Romain Marignier

14.0k total citations
153 papers, 4.2k citations indexed

About

Romain Marignier is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Romain Marignier has authored 153 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Pathology and Forensic Medicine, 93 papers in Neurology and 39 papers in Rheumatology. Recurrent topics in Romain Marignier's work include Multiple Sclerosis Research Studies (117 papers), Peripheral Neuropathies and Disorders (81 papers) and Systemic Lupus Erythematosus Research (32 papers). Romain Marignier is often cited by papers focused on Multiple Sclerosis Research Studies (117 papers), Peripheral Neuropathies and Disorders (81 papers) and Systemic Lupus Erythematosus Research (32 papers). Romain Marignier collaborates with scholars based in France, United States and Germany. Romain Marignier's co-authors include Sandra Vukusic, Christian Confavreux, J. de Sèze, Hélène Zéphir, Kazuo Fujihara, Brian G. Weinshenker, Friedemann Paul, Álvaro Cobo‐Calvo, Pascale Giraudon and Jérôme Honnorat and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Brain.

In The Last Decade

Romain Marignier

138 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Romain Marignier France 36 3.2k 2.7k 1.1k 549 545 153 4.2k
Silvia Tenembaum Argentina 7 2.8k 0.9× 2.1k 0.8× 864 0.8× 349 0.6× 354 0.6× 12 3.2k
Douglas Kazutoshi Sato Brazil 28 2.5k 0.8× 2.2k 0.8× 943 0.8× 362 0.7× 371 0.7× 85 3.2k
Maria Isabel Leite United Kingdom 41 5.1k 1.6× 4.8k 1.8× 2.2k 2.0× 626 1.1× 823 1.5× 93 6.9k
Su‐Hyun Kim South Korea 32 2.6k 0.8× 2.2k 0.8× 822 0.7× 437 0.8× 374 0.7× 120 3.4k
Nasrin Asgari Denmark 25 2.1k 0.7× 1.7k 0.7× 772 0.7× 371 0.7× 294 0.5× 83 2.8k
B. Mark Keegan United States 31 2.0k 0.6× 2.0k 0.8× 653 0.6× 267 0.5× 469 0.9× 96 3.4k
Anu Jacob United Kingdom 36 6.5k 2.1× 5.6k 2.1× 2.2k 2.0× 861 1.6× 846 1.6× 104 8.0k
Kathrin Schanda Austria 23 1.6k 0.5× 1.7k 0.7× 560 0.5× 418 0.8× 422 0.8× 46 2.8k
Maureen A. Mealy United States 29 2.1k 0.7× 1.8k 0.7× 653 0.6× 299 0.5× 204 0.4× 60 2.5k
Noriko Isobe Japan 25 1.3k 0.4× 974 0.4× 546 0.5× 548 1.0× 510 0.9× 129 2.4k

Countries citing papers authored by Romain Marignier

Since Specialization
Citations

This map shows the geographic impact of Romain Marignier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Romain Marignier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Romain Marignier more than expected).

Fields of papers citing papers by Romain Marignier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Romain Marignier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Romain Marignier. The network helps show where Romain Marignier may publish in the future.

Co-authorship network of co-authors of Romain Marignier

This figure shows the co-authorship network connecting the top 25 collaborators of Romain Marignier. A scholar is included among the top collaborators of Romain Marignier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Romain Marignier. Romain Marignier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Catenoix, Hélène, et al.. (2025). Multiple sclerosis and epilepsy. Revue Neurologique. 181(5). 391–396.
2.
Marignier, Romain. (2024). What's new in NMOSD and MOGAD?. Revue Neurologique. 180(9). 957–962. 1 indexed citations
3.
Philippe, Nicolas, Grégory Destras, Antonin Bal, et al.. (2023). Méningo-radiculite à Borrelia miyamotoi sous anti-CD20, identifiée par analyse méta-transcriptomique du LCR. Revue Neurologique. 179. S93–S93.
4.
Fournier, Nicolas, Yvan Jamilloux, Mathieu Gerfaud‐Valentin, et al.. (2023). Minor Salivary Gland Biopsy for the Diagnosis of Neurosarcoidosis. European Neurology. 86(3). 171–177.
5.
Carta, Sara, Le Duy, Véronique Rogemond, et al.. (2023). Anti-Argonaute antibodies as a potential biomarker in NMOSD. Journal of Neurology Neurosurgery & Psychiatry. 94(9). 738–741. 5 indexed citations
6.
Desbois, A.C., Bastien Joubert, Cécile‐Audrey Durel, et al.. (2022). Prognostic Factors and Treatment Efficacy in Spinal Cord Sarcoidosis: An Observational Cohort With Long-term Follow-up.. SPIRE - Sciences Po Institutional REpository. 1 indexed citations
7.
Pique, Julie, Adil Maarouf, Xavier Ayrignac, et al.. (2022). Time to steroids impacts visual outcome of optic neuritis in MOGAD. Journal of Neurology Neurosurgery & Psychiatry. 94(4). 309–313. 18 indexed citations
8.
9.
Mariotto, Sara, Matteo Gastaldi, Luisa Grazian, et al.. (2021). NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders. Multiple Sclerosis and Related Disorders. 50. 102833–102833. 20 indexed citations
10.
Papeix, Caroline, Élisabeth Maillart, J. de Sèze, et al.. (2020). A comparative evaluation of different neuromyelitis optica spectrum disorder sets of criteria. European Journal of Neurology. 27(11). 2250–2256. 3 indexed citations
11.
Louapre, Céline, Evelyne Maillart, Caroline Papeix, et al.. (2020). Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders. Multiple Sclerosis Journal. 26. 86–87. 4 indexed citations
12.
Papp, Viktoria, Melinda Magyari, Orhan Aktaş, et al.. (2020). Worldwide Incidence and Prevalence of Neuromyelitis Optica. Neurology. 96(2). 59–77. 165 indexed citations
13.
Kleerekooper, Iris, Megan K. Herbert, H. Bea Kuiperij, et al.. (2020). CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD. Journal of Neurology Neurosurgery & Psychiatry. 91(6). 605–611. 21 indexed citations
14.
Bernard‐Valnet, Raphaël, Álvaro Cobo‐Calvo, Aurore Siegfried, et al.. (2019). Paraneoplastic neuromyelitis optica and ovarian teratoma: A case series. Multiple Sclerosis and Related Disorders. 31. 97–100. 19 indexed citations
15.
Ciron, Jonathan, Damien Biotti, Anne Ruiz, et al.. (2019). Area postrema syndrome: Another feature of anti-GFAP encephalomyelitis. Multiple Sclerosis Journal. 26(2). 253–255. 16 indexed citations
16.
Collongues, Nicolas, Bertrand Bourre, Damien Biotti, et al.. (2018). Disease activity during pregnancy in patients with AQP4-Ab positive, MOG-Ab positive or double negative NMOSD. Multiple Sclerosis Journal. 24. 541–541. 3 indexed citations
17.
Collongues, Nicolas, David Brassat, Élisabeth Maillart, et al.. (2015). Efficacy of rituximab in refractory neuromyelitis optica. Multiple Sclerosis Journal. 22(7). 955–959. 55 indexed citations
18.
Marignier, Romain, Raphaël Bernard‐Valnet, Pascale Giraudon, et al.. (2013). Aquaporin-4 antibody–negative neuromyelitis optica. Neurology. 80(24). 2194–2200. 127 indexed citations
19.
Verbeek, Marcel M., Zsolt Illés, Romain Marignier, et al.. (2012). Serum GFAP levels in optic neuropathies. Journal of the Neurological Sciences. 317(1-2). 117–122. 30 indexed citations
20.
Vincent, Peggy, Yves Collette, Romain Marignier, et al.. (2005). A Role for the Neuronal Protein Collapsin Response Mediator Protein 2 in T Lymphocyte Polarization and Migration. The Journal of Immunology. 175(11). 7650–7660. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Tenembaum Breakdown of academic impact, for papers by Douglas Kazutoshi Sato Breakdown of academic impact, for papers by Maria Isabel Leite Breakdown of academic impact, for papers by Su‐Hyun Kim Breakdown of academic impact, for papers by Nasrin Asgari Breakdown of academic impact, for papers by B. Mark Keegan Breakdown of academic impact, for papers by Anu Jacob Breakdown of academic impact, for papers by Kathrin Schanda Breakdown of academic impact, for papers by Maureen A. Mealy Breakdown of academic impact, for papers by Noriko Isobe
Rankless by CCL
2026